Search results
Results From The WOW.Com Content Network
In other words, Pfizer's next growth phase could already be starting. This growth should support the dividend High dividend yields can represent a lack of trust in a company's ability to afford ...
The good news on this front, though, is that Pfizer is poised to improve its bottom line and make its dividend even safer. Sure, the big pharma company's earnings fell 11% year over year in Q2.
Pfizer's current 5.73% dividend yield stands well above the S&P 500 average of 1.35%. The company's payout ratio of 443% appears unsustainable at first glance. However, this elevated ratio stems ...
Pharmaceutical giant Pfizer (NYSE: PFE) stands out in this context. The company currently offers a mouthwatering 5.7% dividend yield -- the highest among major drug manufacturers and one of the ...
For premium support please call: 800-290-4726 more ways to reach us
Pfizer beat on earnings in the first quarter of 2024, giving its stock a much-needed 7% boost Wednesday.The company reported $14.9 billion in revenue, down 19% compared to last year. That beat ...
For premium support please call: 800-290-4726 more ways to reach us
With a lot of new drugs to sell, Pfizer expects adjusted earnings to reach a range between $2.15 and $2.35 per share this year, which is more than it needs to meet a dividend commitment currently ...